Mutations in Dag1 or the genes required for its glycosylation result in dystroglycanopathy, a type of congenital muscular dystrophy characterized by a wide range of phenotypes including muscle weakness, brain defects, and cognitive impairment. This evidence concerns the gene DAG1 and congenital muscular dystrophy due to LMNA mutation.